iRhythm Holdings, Inc. (IRTC) stock
IRTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/303% below fair value
$89.67−1.16 (-1.28%)
Close on Nov 17, 2026Market cap $2.96BP/E –Yield –
iRhythm ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
iRhythm's ebitda for the twelve months ending Jun 30, 2026 was -$4.27M. For fiscal 2025 it was -$36.71M. The highest annual figure on record is -$14.52M in fiscal 2014.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$36.71M | – |
| FY2024 | Dec 31, 2024 | -$94.81M | – |
| FY2023 | Dec 31, 2023 | -$108.86M | – |
| FY2022 | Dec 31, 2022 | -$100.38M | – |
| FY2021 | Dec 31, 2021 | -$90.14M | – |
| FY2020 | Dec 31, 2020 | -$36.77M | – |
| FY2019 | Dec 31, 2019 | -$51.31M | – |
| FY2018 | Dec 31, 2018 | -$43.42M | – |
| FY2017 | Dec 31, 2017 | -$25.99M | – |
| FY2016 | Dec 31, 2016 | -$15.01M | – |
| FY2015 | Dec 31, 2015 | -$21.14M | – |
| FY2014 | Dec 31, 2014 | -$14.52M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.66M | – |
| Q1 FY2026 | Mar 31, 2026 | -$11.19M | – |
| Q4 FY2025 | Dec 31, 2025 | $7.49M | +515.1% |
| Q3 FY2025 | Sep 30, 2025 | -$3.23M | – |
| Q2 FY2025 | Jun 30, 2025 | -$13.61M | – |
| Q1 FY2025 | Mar 31, 2025 | -$27.36M | – |
| Q4 FY2024 | Dec 31, 2024 | $1.22M | – |
| Q3 FY2024 | Sep 30, 2024 | -$45.20M | – |
| Q2 FY2024 | Jun 30, 2024 | -$17.78M | – |
| Q1 FY2024 | Mar 31, 2024 | -$33.04M | – |
| Q4 FY2023 | Dec 31, 2023 | -$34.28M | – |
| Q3 FY2023 | Sep 30, 2023 | -$23.50M | – |
| Q2 FY2023 | Jun 30, 2023 | -$15.07M | – |
| Q1 FY2023 | Mar 31, 2023 | -$35.90M | – |
| Q4 FY2022 | Dec 31, 2022 | -$17.20M | – |
| Q3 FY2022 | Sep 30, 2022 | -$17.69M | – |
| Q2 FY2022 | Jun 30, 2022 | -$20.05M | – |
| Q1 FY2022 | Mar 31, 2022 | -$45.45M | – |
| Q4 FY2021 | Dec 31, 2021 | -$29.14M | – |
| Q3 FY2021 | Sep 30, 2021 | -$20.78M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.79M | – |
| Q1 FY2021 | Mar 31, 2021 | -$25.43M | – |
| Q4 FY2020 | Dec 31, 2020 | -$7.60M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.06M | – |
| Q2 FY2020 | Jun 30, 2020 | -$18.56M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.62M | – |
| Q4 FY2019 | Dec 31, 2019 | -$16.54M | – |
| Q3 FY2019 | Sep 30, 2019 | -$17.36M | – |
| Q2 FY2019 | Jun 30, 2019 | -$9.87M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.58M | – |
| Q4 FY2018 | Dec 31, 2018 | -$12.50M | – |
| Q3 FY2018 | Sep 30, 2018 | -$8.62M | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.18M | – |
| Q1 FY2018 | Mar 31, 2018 | -$10.05M | – |
| Q4 FY2017 | Dec 31, 2017 | -$10.45M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.48M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.62M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.45M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.43M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.47M | – |
See a number that looks wrong?